Page 248 - Clinical Small Animal Internal Medicine
P. 248

216  Section 3  Cardiovascular Disease

            250 bpm can induce severe myocardial dysfunction   propagate within specialized muscular bundles of the
  VetBooks.ir  within 3–4 weeks in dogs.                      His–Purkinje conduction system, similar to normal
                                                              sinus beats. However, on occasion, SVTs can display
                                                              wide QRS complexes if a bundle branch block is present.
            Epidemiology
                                                              In these challenging cases, the identification of P‐waves
            Supraventricular tachycardias other than AF are rare in   associated with QRS complexes confirms the origin of
            both dogs and cats.                               the arrhythmia above the His bundle. P‐waves can occur
                                                              before, during or after the QRS complexes. They can be
                                                              positive or negative. Oftentimes,  P‐waves are buried
            Signalment
                                                              within the T‐waves. Although rarely effective, vagal
            Large‐  and  giant‐breed  dogs,  in  addition  to  brachyce­  maneuvers can be done to slow AV conduction, reveal­
            phalic breeds, are more commonly diagnosed with SVTs.   ing hidden P‐waves associated to QRS complexes.
            Tachyarrhythmias associated with an accessory pathway   It is important to consider that ventricular tachycar­
            have more frequently been reported in Labradors.  dias are much more frequent than SVTs. Following care­
                                                              ful examination of the ECG, if uncertainty persists about
                                                              the origin of a wide QRS complex tachycardia, it should
            History and Clinical Signs
                                                              be first treated as if it were ventricular tachycardia.
            Signs of SVTs include weight loss, lethargy, exercise
            intolerance, excessive panting, and dyspnea. However, it   Ambulatory 24‐Hour Holter Recording
            is not uncommon for dogs to be perceived as being non­  The information collected from Holter recordings
            clinical. Owners of dogs with SVTs may report “seeing”   includes the number of episodes and their duration, the
            their pet’s heart pounding in the chest during episodes of   modes of arrhythmia onset and termination, and infor­
            tachycardia. Weakness and transient loss of conscious­  mation about the overall heart rate, especially when the
            ness are less common with SVT. Additionally, SVTs may   animal is in a familiar environment. Evaluation of heart
            only be recognized at the time of physical examination in   rate distribution over 24 hours in the light of an activity
            dogs with signs of congestive heart failure.      log completed by the owner during the period of record­
                                                              ing is a source of valuable information on the circadian
                                                              pattern of the arrhythmia and on the contribution of adr­
            Diagnosis
                                                              energic tone to the initiation and rate of the arrhythmia.
            Physical Examination
            Cardiac auscultation is a useful diagnostic tool to calcu­  Echocardiography
            late heart rate, detect occasional ectopic beats, and dis­  An echocardiogram is useful to assess for the presence of
            tinguish between paroxysmal and sustained arrhythmias.   structural cardiac disease and tachycardia‐induced
            While paroxysmal SVTs are usually regular, SVTs may   cardiomyopathy.
            also be irregular. Some dogs experiencing episodes of
            paroxysmal SVT will be in sinus rhythm at the time of   Therapy
            presentation. Femoral pulses may be weaker during
            bouts of tachycardia.                             Decision to Treat
                                                              Treatment is justified when SVTs cause clinical signs,
            Electrocardiography                               which are directly related to their rate and duration, as
            It is critical to differentiate supraventricular from ven­  well as ventricular performance. In the absence of obvi­
            tricular tachycardia. However, treatment can be initiated   ous clinical signs, treatment should be considered if
            without identifying the exact mechanism of an SVT.  tachycardia‐induced  cardiomyopathy  is  suspected.
             The first step in the diagnosis of tachyarrhythmias is   When SVTs are intermittent, relating the clinical signs to
            recognizing that an uninterrupted and irregular (a varia­  the arrhythmia may be challenging. In that situation,
            tion >100 ms between RR intervals) tachycardia is   long‐term recording of the cardiac rhythm via ambula­
              typically AF. Once AF is ruled out, SVTs must be differ­  tory 24‐hour Holter recording, or preferably with a wear­
            entiated from ventricular tachycardia by looking at the   able or an implantable loop event recorder, is indicated.
            morphology of the QRS complexes. Ventricular tachy­  A rate‐control or rhythm‐control strategy, which con­
            cardias have wide QRS complexes (>0.06 s in dogs;   sists of restoring sinus rhythm, can be applied to the
            >0.04 s in cats) followed by a large T‐wave directed   treatment of SVTs. Drug selection is based on the type of
            opposite to the QRS complex, whereas the main charac­  arrhythmia, the risk of adverse reactions, and the degree
            teristic of SVTs is narrow QRS complexes, indicating   of cardiac dysfunction. Other factors to take into account
            that electrical impulses, once they reach the ventricles,   include decreased oral medication absorption, drug
   243   244   245   246   247   248   249   250   251   252   253